Jill Henrich, EVP, Global Head RA & Quality at Atara Biotherapeutics, Inc. (ATRA), sold 3,879 shares at $0.72 ($3K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Open-market sale of $3k ATRA by EVP, Global Head RA & Quality. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2024-08-20 | $6K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $16K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $1K | — | Filing → |